Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
167
NMPA:167
Drug Approvals
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20254504
- Approval Date
- Jun 10, 2025
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20254503
- Approval Date
- Jun 10, 2025
NMPA
Pitavastatin Calcium Tablets
- Product Name
- 匹伐他汀钙片
- Approval Number
- 国药准字H20243843
- Approval Date
- May 28, 2024
NMPA
Colloidal Bismuth Pectin Capsules
- Product Name
- 胶体果胶铋胶囊
- Approval Number
- 国药准字H20193147
- Approval Date
- Apr 29, 2024
NMPA
Cefmetazole Sodium for Injection
- Product Name
- 注射用头孢美唑钠
- Approval Number
- 国药准字H20234477
- Approval Date
- Nov 14, 2023
NMPA
Cefmetazole Sodium for Injection
- Product Name
- 注射用头孢美唑钠
- Approval Number
- 国药准字H20234478
- Approval Date
- Nov 14, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
Clinical Trials
No trials found
News
No news found